End-of-day quote
Other stock markets
|
||
- | - |
06-03 | Neurogene's Gene Therapy For Rett Syndrome Picked For FDA Pilot Program | MT |
06-03 | Neurogene Inc. Announces NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for Start Pilot Program | CI |
Official Publications
No official publication found
- Stock Market
- Equities
- NGNE Stock
- Stock
- News Aquinox Pharmaceuticals Inc
- Official Publications